Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 11 of 1006 for:    BMD

An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02907619
Recruitment Status : Terminated (Termination Date: 30Aug2018; Reason for termination: Lack of Efficacy)
First Posted : September 20, 2016
Last Update Posted : May 10, 2019
Sponsor:
Information provided by (Responsible Party):
Pfizer

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Terminated
Actual Primary Completion Date : November 22, 2018
Actual Study Completion Date : November 22, 2018
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 September 18, 2019
October 8, 2019
2 November 4, 2019